Cardiac Biomarkers Market Research Report 2021: Global Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2021-2026 - ResearchAndMarkets.com

The "Cardiac Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The global cardiac biomarkers market reached a value of US$ 8.2 Billion in 2020. Looking forward, the global cardiac biomarkers market to exhibit moderate growth during the next five years.

Cardiac markers, also known as cardiac biomarkers, are released into the bloodstream when the heart is stressed, or its muscles are damaged. These markers include different types of enzymes, hormones, and proteins, such as cardiac troponins, creatine kinase (CK), ischemia-modified albumin (IMA), and myoglobin.

Measurement and testing of these markers can help in diagnosing heart conditions like cardiac ischemia and acute coronary syndrome (ACS). At present, the triage and diagnostic systems used for determining the risk of these conditions are based on electrocardiograms (ECGs) and clinical history.

However, these systems are insufficient and can lead to misdiagnosis or delay in treatment. As cardiac marker testing offers higher accuracy and can identify the conditions in the early stages of presentation, they are gaining traction across the globe. These markers can also help in monitoring the prognosis of these condition with greater accuracy and providing the most effective treatment to the patients.

Global Cardiac Biomarkers Market Drivers:

Over the past few years, there has been a rise in the number of patients suffering from ACS which has created a demand for cardiac marker testing at a global level. Other than this, rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs is driving the demand for these markers. In addition, there are numerous private and public organizations which are investing in R&D activities to develop advanced technologies in the field of cardiac biomarkers.

For instance, blood tests for high-sensitivity cardiac troponin I have been demonstrated to identify patients who are at a higher risk of a second heart attack. Moreover, high accuracy and rapid results offered by biomarker testing, coupled with the availability of affordable cardiac point-of-care testing, are some of the other factors which are contributing to the growth of the market.

Key Questions Answered in This Report:

• How has the global cardiac biomarkers market performed so far and how will it perform in the coming years?
• What are the key regional markets in the global cardiac biomarkers industry?
• What has been the impact of COVID-19 on the global cardiac biomarkers industry?
• What is the breakup of the global cardiac biomarkers market on the basis of type?
• What is the breakup of the global cardiac biomarkers market on the basis of location of testing?
• What is the breakup of the global cardiac biomarkers market on the basis of application?
• What are the various stages in the value chain of the global cardiac biomarkers market?
• What are the key driving factors and challenges in the global cardiac biomarkers market?
• What is the structure of the global cardiac biomarkers market and who are the key players?
• What is the degree of competition in the global cardiac biomarkers market?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Cardiac Biomarkers Market

5.1 Market Overview

5.2 Market Performance

5.3 Impact of COVID-19

5.4 Market Breakup by Type

5.5 Market Breakup by Location of Testing

5.6 Market Breakup by Application

5.7 Market Breakup by Region

5.8 Market Forecast

6 Market Breakup by Type

6.1 Troponins (T and I)

6.1.1 Market Trends

6.1.2 Market Forecast

6.2 Myocardial Muscle Creatine Kinase (CK-MB)

6.3 Myoglobin

6.4 Brain Natriuretic Peptide (BNPs) or NT-proBNP

6.5 Ischemia Modified Albumin (IMA)

7 Market Breakup by Location of Testing

7.1 Laboratory Testing

7.2 Point of Care Testing

8 Market Breakup by Application

8.1 Myocardial Infarction

8.2 Congestive Heart Failure

8.3 Acute Coronary Syndrome

8.4 Atherosclerosis

9 Market Breakup by Region

10 Global Cardiac Biomarkers Industry: SWOT Analysis

10.1 Overview

10.2 Strengths

10.3 Weaknesses

10.4 Opportunities

10.5 Threats

11 Global Cardiac Biomarkers Industry: Value Chain Analysis

12 Global Cardiac Biomarkers Industry: Porters Five Forces Analysis

12.1 Overview

12.2 Bargaining Power of Buyers

12.3 Bargaining Power of Suppliers

12.4 Degree of Competition

12.5 Threat of New Entrants

12.6 Threat of Substitutes

13 Global Cardiac Biomarkers Industry: Price Analysis

14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

• Abbott Laboratories
• Alere Inc.
• Beckman Coulter
• Becton
• Dickinson And Co.
• Biomerieux
• Bio-Rad Laboratories
• Randox Laboratories
• Roche Diagnostics Corporation
• Siemens Healthcare
• Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/r/e0kyf1

View source version on businesswire.com: https://www.businesswire.com/news/home/20210610005541/en/